Q

QuantumLeap

Quantum computing for enterprise optimization

AI/MLSeries A$50M - $100M
Final Score
75
Tier 2: High Growth / Low Moat

Negotiate valuation

Investment Decision

Tier 2: High Growth / Low Moat

Likely burn-heavy with stiff competition

Recommended Action

Negotiate valuation

Headquarters

Cambridge, MA

Founded

2022

Employees

60-80

About

QuantumLeap brings quantum computing advantages to enterprise optimization problems. Our hybrid quantum-classical platform solves complex logistics, finance, and drug discovery challenges 1000x faster than traditional methods.

Weighted Scoring Breakdown
Execution Power

Weight: 30%

85.0

Founder-Market Fit + Revenue Velocity

Capital Efficiency

Weight: 30%

67.5

Burn Multiple + LTV/CAC

Durable Moat

Weight: 25%

75.0

Proprietary Data + Integration Depth

Growth Potential

Weight: 15%

67.5

NRR + K-Factor

Evaluation Metrics (1-100 Scale)
Founder-Market FitTarget: 10+ yrs domain + serial exit

20 yrs domain exp + serial exit

Revenue VelocityTarget: >200% YoY Growth

120% YoY ARR Growth

Burn MultipleTarget: <1.0x

1.89x (Net Burn / Net New ARR)

LTV/CAC RatioTarget: >5x

6.0x ($250K / $42.0K)

Proprietary DataTarget: >80%

94% private data

Integration DepthTarget: >5 active hooks

3.8 avg APIs per user

Net Revenue RetentionTarget: >120%

128% NRR

K-FactorTarget: >1.0

0.38 (1.2 invites x 32% conv)

Key Employees
DATJ

Dr. Alan Turing Jr.

CEO & Founder

MIT Quantum Computing Lab, 20+ publications

DML

Dr. Mei Lin

Chief Scientist

Former IBM Quantum, led Q Network

RH

Richard Hayes

VP Business Dev

Former BCG, quantum practice leader

Financial Metrics

Revenue (ARR)

$5.8M ARR

+120% YoY

Gross Margin

76%

Burn Rate

$600K/month

Runway

20 months

LTV

$250,000

CAC

$42,000

Investment Details
Total Raised$32M
Last Round$25M Series A
Last Round DateFebruary 2025
Target Raise$75M Series B
Minimum Investment$150,000

Lead Investors

IQTBessemer Venture Partners
Key Highlights
  • Founded by MIT quantum computing pioneers
  • 1000x speedup on optimization problems
  • Partnerships with 3 Fortune 100 pharma companies
  • 8 patents on hybrid quantum algorithms
Risk Factors
  • Nascent quantum computing market
  • Hardware dependency on third-party quantum providers
  • Long enterprise sales cycles